Title : Rapamycin enhances survival in a Drosophila model of mitochondrial disease.

Pub. Date : 2016 Dec 6

PMID : 27741510






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our lab has recently shown that genetic inhibition of the mechanistic target of rapamycin (TOR) rescues the short lifespan of yeast mutants with defective mitochondrial function, and that pharmacological inhibition of TOR by administration of rapamycin significantly rescues the shortened lifespan, neurological symptoms, and neurodegeneration in a mouse model of LS. Sirolimus Target of rapamycin Drosophila melanogaster
2 Our lab has recently shown that genetic inhibition of the mechanistic target of rapamycin (TOR) rescues the short lifespan of yeast mutants with defective mitochondrial function, and that pharmacological inhibition of TOR by administration of rapamycin significantly rescues the shortened lifespan, neurological symptoms, and neurodegeneration in a mouse model of LS. Sirolimus Target of rapamycin Drosophila melanogaster